RELATED CONTENT
NEWS
- Vanda, Probiomed in deal for schizophrenia drug Fanapt for Mexico
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- Pharming waterproofs cash liferaft as delays takes wind out of US Rhucin sales
- SuperGen rises 8.8% on US FDA acceptance of Dacogen sNDA in AML

